Project overview
The overall purpose of my research work is to investigate a novel combination of agents to improve the outcome of children with high-risk neuroblastoma. Specifically, we will utilise established pre-clinical models to investigate whether the efficacy of anti-GD2 and isotretinoin in neuroblastoma can be enhanced by the addition of EZH2 inhibitors, obtaining data to support the translation into clinical trials.
Staff
Lead researcher
Other researchers
